{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:05:43Z","timestamp":1786997143664,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"12-13","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.steroids.2013.09.003","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T03:33:26Z","timestamp":1379475206000},"page":"1273-1280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Tissue selectivity of ospemifene: Pharmacologic profile and clinical implications"],"prefix":"10.1016","volume":"78","author":[{"given":"Lauri","family":"Kangas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Unkila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2013.09.003_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0029-1216280","article-title":"Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials","volume":"27","author":"Barrett-Connor","year":"2009","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.steroids.2013.09.003_b0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of The North American Menopause Society","volume":"19","author":"North American Menopause Society","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2013.09.003_b0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-157-2-201207170-00466","article-title":"Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations","volume":"157","author":"Nelson","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.steroids.2013.09.003_b0205","doi-asserted-by":"crossref","first-page":"13879","DOI":"10.1074\/jbc.M110.187849","article-title":"Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells","volume":"286","author":"Dong","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2013.09.003_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fendo.2012.00019","article-title":"Tissue-specific effects of loss of estrogen during menopause and aging","volume":"3","author":"Wend","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.steroids.2013.09.003_b0030","first-page":"448","article-title":"Ospemifene hormos","volume":"5","author":"Gennari","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.steroids.2013.09.003_b0210","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1177\/1933719113497290","article-title":"Profile of ospemifene in the breast","volume":"20","author":"Berga","year":"2013","journal-title":"Reprod Sci"},{"key":"10.1016\/j.steroids.2013.09.003_b0040","series-title":"Full prescribing information","author":"Osphena\u2122 (ospemifene)","year":"2013"},{"key":"10.1016\/j.steroids.2013.09.003_b0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.steroids.2013.09.003_b0050","unstructured":"http:\/\/www.census.gov\/2010census>; 2013 [accessed 13.02.13]."},{"key":"10.1016\/j.steroids.2013.09.003_b0055","unstructured":"IMS Health Plan Claims [Apr 2008\u2013Mar 2011]."},{"key":"10.1016\/j.steroids.2013.09.003_b0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.04.004","article-title":"Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause","volume":"138","author":"Unkila","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2013.09.003_b0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0378-5122(02)00206-2","article-title":"Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women","volume":"43","author":"Voipio","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2013.09.003_b0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00042192-200512020-00015","article-title":"Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women","volume":"12","author":"Komi","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2013.09.003_b0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.GME.0000063609.62485.27","article-title":"Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial","volume":"10","author":"Rutanen","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2013.09.003_b0080","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","article-title":"Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study","volume":"17","author":"Bachmann","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2013.09.003_b0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy","volume":"20","author":"Portman","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2013.09.003_b0215","article-title":"Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy","author":"Goldstein","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.steroids.2013.09.003_b0220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jsbmb.2011.05.001","article-title":"The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk","volume":"126","author":"Williams-Brown","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2013.09.003_b0120","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/gme.0b013e31826d36ba","article-title":"One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2013.09.003_b0125","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","article-title":"Unopposed estrogen therapy and the risk of invasive breast cancer","volume":"166","author":"Chen","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.steroids.2013.09.003_b0130","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/endo.141.2.7342","article-title":"Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats","volume":"141","author":"Qu","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2013.09.003_b0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(01)00066-8","article-title":"In vitro and in vivo biologic effects of ospemifene (FC-1271a) in breast cancer","volume":"77","author":"Taras","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2013.09.003_b0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/gme.0b013e318223e82a","article-title":"Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model","volume":"19","author":"Burich","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2013.09.003_b0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jsbmb.2005.06.027","article-title":"Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice","volume":"97","author":"Wurz","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2013.09.003_b0150","doi-asserted-by":"crossref","first-page":"R881","DOI":"10.1186\/bcr1317","article-title":"Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ","volume":"7","author":"Namba","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.steroids.2013.09.003_b0155","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2005.01.172","article-title":"Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase","volume":"23","author":"Gutierrez","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.steroids.2013.09.003_b0160","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/(SICI)1097-4644(19990615)73:4<500::AID-JCB8>3.0.CO;2-E","article-title":"Comparative effects of estrogen and antiestrogens on differentiation of osteoblasts in mouse bone marrow culture","volume":"73","author":"Qu","year":"1999","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.steroids.2013.09.003_b0165","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.bjp.0707232","article-title":"Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro","volume":"151","author":"Michael","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.steroids.2013.09.003_b0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/09513590410001672197","article-title":"Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women","volume":"18","author":"Komi","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.steroids.2013.09.003_b0175","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00774-006-0689-9","article-title":"Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women","volume":"24","author":"Komi","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.steroids.2013.09.003_b0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/gme.0b013e31821f92df","article-title":"Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review","volume":"19","author":"Tan","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2013.09.003_b0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI115588","article-title":"Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation","volume":"89","author":"Chow","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2013.09.003_b0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jbmr.5650020206","article-title":"The effects of ovariectomy and 17 beta-estradiol on cortical bone histomorphometry in growing rats","volume":"2","author":"Turner","year":"1987","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.steroids.2013.09.003_b0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.abb.2010.07.006","article-title":"Female reproductive system and bone","volume":"503","author":"Clarke","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.steroids.2013.09.003_b0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1098\/rsif.2009.0282","article-title":"Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures","volume":"7","author":"McNamara","year":"2010","journal-title":"J R Soc Interface"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X13001992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X13001992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T04:51:11Z","timestamp":1646542271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X13001992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":36,"journal-issue":{"issue":"12-13","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0039128X13001992"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2013.09.003","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue selectivity of ospemifene: Pharmacologic profile and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2013.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}